Digital twins are virtual representations of an object or system that spans its lifecycle, is updated from real-time data, and use simulation, machine learning and reasoning to help decision-making (IBM). In most cases, this helps data scientists understand how products are operating in production environments and anticipate how they may behave overtime. But what happens when a digital twin is that of a human being?
By using digital twins to model a person, you can use technologies like
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists
What You Should Know:
- Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, a global leader for pathology artificial intelligence (AI) software with world-class industry experts in the development of AI algorithms to provide precision and speed in clinical pathology.
- Together, Tribun Health and Mindpeak help pathologists analyze whole-slide-images (WSI) of immunohistochemically (IHC) stained human
Read More
NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers
What You Should Know:
- NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS).
- This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More
UCLA Research Uses Saliva to Detect Cancer Biomarkers
What You Should Know:
- Spectrum Solutions, LLC announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry that successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva.
- Specifically, amplified EGFR mutations associated with non-small cell lung cancer (NSCLC) using Spectrum’s saliva collection and preservation system with the Electric
Read More
When It Comes to Digital Health, Experience Is Everything
Thanks to COVID-19 and numerous other factors, the adoption of digital health technologies used by patients in the home has skyrocketed. Accenture reported in 2021, for example, that remote patient monitoring technology adoption tripled among patients. Whether it is streaming video telehealth appointments with a provider, a remote patient monitoring platform, or a prescribed digital therapeutic to manage a chronic condition, the emphasis must be on the patient and caregiver
Read More
Syapse and Pierian Partner to Power Precision Oncology
What You Should Know:
- Syapse, a real-world evidence company is teaming up with Pierian®, a provider of advanced clinical genomics technology on a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida.
- The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and precision medicine services that provide the most relevant
Read More
BestLife Holdings Raises $50M+ Portfolio Expansion with Cenegenics
What You Should Know:
- BestLife Holdings, a portfolio of personalized preventative healthcare and age management solutions, announces its formation with a combined equity round of over $50M. Notable investors have partnered with BestLife including PrimeTime Partners’ founders, Abby Levy, the co-founder of Thrive Global with Arianna Huffington, and Alan Patricof, founder of Greycroft Partners and Apax Partners, who also joined the board as an observer. Consumer and digital health
Read More
Imagene Raises $21.5M to Expand Image-Based Biomarker Detection for Precision Medicine
What You Should Know:
- Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced it raised $21.5 million, comprising $3M in seed funding led by Blumberg Capital and an $18.5M Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura.
- The use of AI-based molecular testing in cancer diagnostics is revolutionizing patient care by offering a new level of
Read More
Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions
What You Should Know:
- Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care.
- Through this research agreement, VUNO will establish a collaboration with Mayo Clinic to develop innovative AI and machine learning solutions for more precise diagnosis, prognosis and treatment stratification in cancer.
- This collaborative agreement combines
Read More
Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials
What You Should Know:
- Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC
Read More
